Keudell Regeneron Pharmaceuticals, Inc. Transaction History

Keudell

$341 Million
Q2 2024

A detailed history of Keudell transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Keudell holds 384 shares of REGN stock, worth $388,922. This represents 0.12% of its overall portfolio holdings.

Number of Shares

384

Previous 384 -0.0%

Holding current value

$388,922

Previous $369,000 9.21%

% of portfolio

0.12%

Previous 0.11%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 12, 2022	SELL	$573.97 - $724.32 $17,219 - $21,729	-30 Reduced 7.25%	384 $265,000
Q2 2022 Jul 18, 2022	SELL	$548.35 - $738.84 $28,514 - $38,419	-52 Reduced 11.16%	414 $245,000
Q1 2022 Apr 18, 2022	SELL	$595.12 - $698.43 $3,570 - $4,190	-6 Reduced 1.27%	466 $325,000
Q4 2021 Feb 08, 2022	SELL	$543.48 - $670.97 $62,500 - $77,161	-115 Reduced 19.59%	472 $298,000
Q3 2021 Oct 20, 2021	SELL	$574.03 - $680.96 $22,387 - $26,557	-39 Reduced 6.23%	587 $355,000
Q1 2021 Apr 13, 2021	SELL	$446.73 - $548.2 $195,667 - $240,111	-438 Reduced 41.17%	626 $296,000
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $2,391 - $3,039	-5 Reduced 0.47%	1,064 $514,000
Q3 2020 Oct 20, 2020	SELL	$544.75 - $658.21 $12,529 - $15,138	-23 Reduced 2.11%	1,069 $598,000
Q1 2020 Apr 20, 2020	BUY	$336.18 - $494.43 $20,170 - $29,665	60 Added 5.81%	1,092 $533,000
Q4 2019 Jan 29, 2020	SELL	$274.13 - $376.51 $55,374 - $76,055	-202 Reduced 16.37%	1,032 $387,000
Q3 2019 Nov 13, 2019	BUY	$273.46 - $318.39 $8,203 - $9,551	30 Added 2.49%	1,234 $342,000
Q2 2019 Aug 23, 2019	BUY	$299.6 - $414.82 $360,718 - $499,443	1,204 New	1,204 $364,000
Q2 2019 Aug 21, 2019	SELL	$299.6 - $414.82 $364,313 - $504,421	-1,216 Closed	0 $0
Q1 2019 Aug 21, 2019	BUY	$372.08 - $439.57 $452,449 - $534,517	1,216 New	1,216 $499,000

Others Institutions Holding REGN

# of Institutions

1,464

Shares Held

84.4M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $109B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keudell, based on Form 13F filings with the SEC.

News

Stay updated on Keudell with notifications on news.

Account